s6y
Company name or ticker
Search
Oruka Therapeutics, Inc.
424B5
Prospectus filed pursuant to Rule 424(b)(5)
Filed
Monday, August 21, 2017
Accession number
0001193125-17-263724
Documents
424B5
424B5
On sec.gov
Filing index
All files
Complete submission text
SGML header